15 Innovative Medical Device Companies Seeking Distributors and Hospital Partners for Products Including Surgical Robots, Imaging Equipment, and In Vitro Diagnostic Analyzers – National Day Special Matchmaking Session

Innovation is the inexhaustible driving force for the development of the medical device industry. The state highly values medical devices as a crucial national asset and has introduced a series of policies to support the innovative development of the medical device industry.VCBeatSupply and Demand Connection Selection - National Day Special, This IssueBring to everyone15 ModelsMedical DeviceProducts, Seeking High QualityCooperation with Dealers and Related Hospital Resources, details as follows:

●Company/Product Introduction:

● Demand Description:

Recruit dealers and partners in the field of structural heart disease.

● Company/Product Introduction:

Nanjing Eaglenos Co., Ltd. is a new technology-oriented company focused on research and development, dedicated to providing customers with high-value and innovative products.

China's First "All-Dry" Blood Gas and Electrolyte Analyzer, primarily based on electrochemical and microfluidic chip technology, embodies the concept of transferring analytical laboratory functions onto a chip. It integrates electrodes, calibration solutions, airbags, pumps, fluid pathways, and waste chambers onto a single-use card. Each test uses a brand-new pathway and electrode; aside from the test card, there are no other consumables, no additional reagent packs required, and it eliminates complicated maintenance processes. Additionally, the company’s electrolyte products feature exclusive free magnesium detection, complementing common tests for potassium ions, sodium ions, ionized calcium, and chloride ions, offering greater clinical application value.

● Demand Description:

Seeking distributors for small critical care resources in departments such as anesthesia, respiratory, intensive care, ICU, CCU, NICU, etc.

● Company/Product Introduction:

QUANMAG, with ultra-sensitive weak magnetic detection and imaging as its core technology, focuses on the independent research, development, and production of liquid-helium-free quantum magnetoencephalography (MEG). It has obtained the world's first NMPA certification for a liquid-helium-free MEG system. The liquid-helium-free quantum MEG enables non-invasive, radiation-free millisecond-level detection of neural activity and millimeter-level localization of lesions and functional areas.

As a technological innovator in magnetoencephalography (MEG), QUANMAG has developed a next-generation optically pumped magnetometer (OPM) as its core technology, creating a liquid-helium-free quantum MEG closed-loop technical platform that integrates precision weak magnetic detection, efficient magnetic shielding, and high-resolution magnetic inversion. The company has also led the completion of China's first quantum MEG patent layout and published the first results of quantum sensing-based MEG brain activity detection.

●Demand Description:

Medical Clients: Neurosurgery, Neurology, Psychiatry, and Imaging Departments of tertiary or higher general hospitals; or specialized hospitals for brain diseases and mental illnesses.

Research Clients: Universities and laboratories in the fields of brain science, cognitive neuroscience, and psychology.

● Company/Product Introduction:

Shenzhen Angell Technology Co., Ltd. focuses on the technological exploration, product development and production, and sales of digital medical imaging products and corresponding system software. Angell Technology has grown into one of the world's top ten core manufacturers of X-ray equipment and a global leader in X-ray innovation technology. It is the only medical high-tech company in the world to achieve full industrial chain autonomy and control over the three core component technologies (detector, X-ray tube, high-voltage generator) and the complete machine R&D and manufacturing technology of X-ray systems. As the only Chinese company honored as the "Single Manufacturing Champion" in the digital X-ray machine industry, it is an undisputed global leader in X-ray innovation technology.

● Demand Description:

Shenzhen Angell Technology Co., Ltd. is seeking agents for its WR-3D weight-bearing cone beam CT and mobile dynamic DR products.

●Company/Product Introduction:

Wudu is a high-end brand of children's nebulizers under Shenzhen Homed Medical Device Co., Ltd. Homed Medical was established in 2003 and has been focusing on the research and development of respiratory diagnosis and treatment equipment + service platforms for 20 years, continuously innovating products and persisting in technology. To date, Homed Medical has obtained more than 70 patents at home and abroad and has been successively rated as a "National High-tech Enterprise" and a "Specialized and Refined Enterprise." Its products are sold to 45 countries and regions worldwide. The company produces more than 2 million nebulizers annually. Jiari Kang, the high-end brand under the company, is the pioneer of standardized intelligent nebulization centers. So far, it has built over 3,500 standardized nebulization centers across China, and more than 70% of the nebulization rooms in tertiary children's hospitals in China use Jiari Kang products.

● Demand Description:

Recruitment Agent:

① Enterprises or individuals with their own sales terminals are not supported for distribution of this product.

② In-hospital device stores, device stores around hospitals, and those with high-end nebulizer sales channels.

● Company/Product Introduction:

Kuoran Medical focuses on providing next-generation pathology (NGP) solutions based on a multiplex immunofluorescence technology platform. The solution integrates staining, imaging, and analysis, including the Kreep staining kit, Krast fully automatic stainer, KR-HT5 high-throughput fluorescent pathology slide scanner, KRIAS medical pathology image analysis system, as well as professional data mining and analysis services.

KR-HT5 was approved for China's Class II Medical Device Registration Certificate on November 22, 2023. It is a high-throughput fluorescence pathology slide scanner that utilizes multispectral unmixing technology to achieve fully automated quantitative pathology imaging of nine markers on a single slide. Equipped with an 80-slide tray, it enables unattended, high-throughput, ultra-high-speed scanning and imaging, effectively improving testing efficiency. This platform transitions from qualitative traditional IHC to quantitative mIHC, addressing the key pain points of current traditional immunohistochemistry techniques, such as difficulty in multi-marker staining, quantitative analysis, and lack of in-situ spatial information, thereby promoting innovation in pathology technology.

●Demand Description:

Seeking Dealer Market Partners.

Hefei Hebin Intelligent Robot Co., Ltd. is a national high-tech enterprise with a focus on intelligent medical care as its key research and development direction. The company specializes in cutting-edge technologies such as remote operation, intelligent robots, ultrasound-assisted diagnosis, and artificial intelligence, aiming to build a full-chain intelligent ultrasound service platform centered around "AI + robotics + ultrasound."

Intelligent Remote Ultrasound Robot Receives NMPA Class III Medical Device Registration ApprovalThe intelligent remote ultrasound robot has been approved for a Class III medical device registration certificate by the National Medical Products Administration (NMPA). The product features an ergonomic and lightweight design, equipped with a 7-axis robotic arm for enhanced flexibility and safety. It delivers aerospace-grade precision control to accurately replicate a doctor's techniques. The system offers plug-and-play AI-assisted diagnostic capabilities with comprehensive artificial intelligence coverage. With mouse-like operation, it requires no training for quick adoption. Joint force and multi-modal environmental perception ensure safe human-machine interaction.

Intelligent remote ultrasound robot products feature high-precision remote control, low latency (<200ms), proactive safety strategies, and comprehensive human-machine interaction security safeguards.

● Demand Description:

We sincerely invite distributors, agents, and hospital offices in need to cooperate in the ultrasound field.

TowardPi's "Intelligent Microscope System" is an ophthalmic surgical device that integrates advanced imaging technology and precise navigation. The product consists of the following core modules:

1. Digital 3D Ophthalmic Surgical Microscope Module:

Utilizing an advanced optical system, it provides a high-definition 3D view, allowing doctors to perform surgeries on a large screen, thus overcoming the limitations of traditional eyepieces.

2. Real-time intraoperative OCT 3D module:

Combining OCT tomographic images with 3D modeling technology, three-dimensional image information is presented in real time, greatly improving the accuracy of lesion localization and the timeliness of surgery.

3. Characteristics of the Optical System:

The optical system of this microscope has been specially designed to meet the stringent requirements of ophthalmic surgery. It includes high-performance objective and eyepiece lenses, ensuring clear images from different angles and distances.

The optical system features a flexible focusing function, allowing for rapid switching between macro and micro perspectives within an extremely short time to meet various surgical needs. The system is also equipped with advanced lighting technology, including coaxial illumination and transmitted light illumination, providing uniform and shadow-free lighting for the surgical area.

●Demand Description:

Sincerely invite ophthalmology institutions to cooperate and negotiate.

Focus on the research and development of non-invasive continuous glucose monitoring algorithms and remote intelligent medical technology. With a decade of in-depth scientific research in the field of non-invasive continuous glucose monitoring, participate in multiple national key research projects and provide reliable product technology.

Product Advantages:

①The product currently has considerable profit and operational space for collaboration models; provincial and municipal agencies are exclusive.

②The underlying technology principle is near-infrared spectroscopy + dynamic metabolic heat + heart rate blood flow velocity, plus a three-layer model, which is different from general products on the market.

③Strict price control across the network, strong product value perception

④Full-Media Matrix Promotion

⑤ Solve the Two Pain Points of Continuous Blood Glucose Monitoring: Needle Pricks and Consumables Repurchase.

● Demand Description:

Partner Profile

① Hope is that there are enterprises or individuals with terminal resources capable of handling product channels.

②Resources in chronic disease management, reverse sugar management, post-examination health management, or doctor-patient interaction, health products, electronic products and related industries.

③ Possesses product supply chain integration capabilities

Hiwise Medical (Beijing) Technology Co., Ltd. is a national high-tech enterprise dedicated to the research, development, production, sales, and service of advanced medical imaging equipment, intelligent medical imaging equipment, and related technologies. Its main products include digital X-ray imaging systems (orthopedic and neurosurgical mobile flat-panel G-arm 2D and 3D imaging products), mobile flat-panel G-arm X-ray machines, and mobile flat-panel C-arm X-ray machines.

● Demand Description:

Looking for agents and distributors.

Chengdu Feiming Technology Co., Ltd. is an innovative medical device research and development company. The company utilizes computer technologies such as virtual reality, computer vision, and big data to develop a variety of "musculoskeletal rehabilitation and neurological rehabilitation" medical device products, aiming to help patients achieve the clinical goal of motor dysfunction rehabilitation through human-computer intelligence and the integration of sports and medicine.

"Neck Movement Assessment and Rehabilitation Training System" is the first Class II innovative medical device developed by the company, and has been selected as a key medical device project in Sichuan Province. This device pioneers the application of virtual reality technology in the field of clinical rehabilitation, providing rehabilitation support for patients with neck pain through exercise therapy. Its research findings have been published in an SCI journal. The "Intelligent Assessment and Rehabilitation System for Stroke Motor Disorders" has been shortlisted for the "2021 Artificial Intelligence Medical Device Innovation Task" list by the Ministry of Industry and Information Technology and the National Medical Products Administration. Currently, this product has entered the registration phase. Additionally, the company is developing other cutting-edge products such as the "Shoulder Movement Assessment and Rehabilitation Training System," "Intelligent Assessment and Rehabilitation System for Lower Limb Motor Disorders in Stroke Patients," and the "Stroke Eye Movement Stability Assessment and Rehabilitation System."

● Demand Description:

Recruit ecological partners related to "virtual reality therapy and exercise therapy," including pharmaceutical and medical device enterprises, equipment distributors and agents, research institutes/hospitals, etc.

Beijing Yaguo Technology Co., Ltd., focusing on innovation in medical devices and solutions in the field of airway management and respiratory treatment, is a national high-tech enterprise integrating R&D, production, and sales. The Respiratory Neuromuscular Stimulator is a therapeutic device that can effectively improve pulmonary ventilation function and promote respiratory rehabilitation. Due to its significant effects, it has received widespread clinical acclaim and support. Its coverage in China's top 100 hospitals exceeds 80%, including PLA General Hospital, Beijing Tiantan Hospital, the First Affiliated Hospital of Zhengzhou University, Shanghai Zhongshan Hospital, the Third Affiliated Hospital of Sun Yat-sen University, and the First Affiliated Hospital of Chongqing Medical University, among hundreds of hospitals with installations. At the same time, it has been sold to more than 10 countries in Europe and over 30 countries globally, covering Asia, Europe, Oceania, and Latin America.

● Demand Description:

Recruit product distributors, related hospitals, and other ecosystem partners.

Hangzhou Leyi Biotechnology Co., Ltd., wholly owns and controls three subsidiaries: Le Wei Health, Le Ya Biotechnology, and Maisuo Medical. The company focuses on the research and innovation of cutting-edge biotechnologies in exhaled molecular diagnostics and is dedicated to the rapid diagnosis and early screening of multi-system diseases, including digestive disorders. It is a comprehensive enterprise integrating R&D, production, marketing, and service.

The independently developed Bioleya® (LeYa) exhaled gas analyzer, is the first domestically produced device approved for marketing in China. It adopts the "stationary + gas chromatography" methodology and meets the dual certifications of both international "gold standard" and Chinese "national standard." It is currently widely used in clinical settings and is in the process of forming a consensus among Chinese experts, deepening discipline applications, standardizing industry norms, and promoting technological innovation.

●Demand Description:

Recruitment of agents, distributors, and various types of cooperative resource对接needs.

- VCBeat Supply and Demand Platform covers: overseas expansion, supply chain, market/channel, achievement transformation, investment attraction and residency.

- By uploading supply or demand resources through the platform, you can accurately reach target potential partners.

- Efficiently connect with MNCs, startups, government parks, investment institutions, and other entities.